Regular ArticleICSAT Overexpression Is Not Sufficient to Cause Adult T-Cell Leukemia or Multiple Myeloma
References (12)
- et al.
Cell
(1986) - et al.
Blood
(1995) - et al.
Nucleic Acids Res.
(1995) - et al.
Genes. Dev.
(1995) - et al.
Mol. Cell. Biol.
(1996)
Cited by (17)
Lineage- and Stage-Specific Oncogenicity of IRF4
2022, Experimental HematologyCitation Excerpt :However, animal models that demonstrate the oncogenicity of IRF4 in vivo have not been reported until recently [105]. A study overexpressed IRF4 under the Eμ promoter in mouse models, but there was no tumors developed [106]. This is a marked contrast to MYC, an immediate downstream target of IRF4, that can cause cancers in various tissues, including immature lymphoid neoplasms.
Interferon Regulatory Factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation
2011, Journal of Biological ChemistryCitation Excerpt :IRF-4 represses expression of certain genes implicated in the mitotic checkpoint, DNA repair, apoptosis, metastasis, and immune recognition and may provide important functions critical to the emergence of adult T cell leukemia (9–11). Interestingly, IRF-4 alone is apparently not sufficient for oncogenesis in transgenic mice overexpressing IRF-4 in lymphocytes (12), suggesting that additional factors are required for the oncogenic activity of IRF-4 in vivo. Moreover, the cellular environments may determine its specific functions.
The interferon regulatory factors and oncogenesis
2000, Seminars in Cancer BiologyIRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma
2022, Nature CommunicationsLARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT
2021, Gematologiya i TransfusiologiyaCD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
2015, Journal of Clinical Pathology
- 1
To whom correspondence should be addressed. Fax: +81-3-5804-6261. E-mail: [email protected].